C. Leonardi

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

Delano Pathirana, AD Ormerod, P. Saïag et al. · Journal of the European Academy of Dermatology and Venereology · 2009 · 700 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

A classification of psoriasis vulgaris according to phenotype

C.E.M. Griffiths, Enno Christophers, Juliet N. Barker et al. · British Journal of Dermatology · 2006 · 292 citations

Medicine, Clinical Sciences, Dermatology +11

Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (<scp>SCULPTURE</scp> Extension Study)

Robert Bissonnette, Thomas A. Luger, Diamant Thaçi et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 193 citations · Full text

Medicine, Dermatology, Pharmacotherapy +16

Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches

Andrew Blauvelt, J.‐P. Lacour, Joseph F. Fowler et al. · British Journal of Dermatology · 2018 · 147 citations

Medicine, Clinical Sciences, Pharmacotherapy +14

Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

Alice B. Gottlieb, C. Leonardi, Francisco A. Kerdel et al. · British Journal of Dermatology · 2011 · 127 citations

Medicine, Pharmacology, Pharmacotherapy +14